感觉好一些了吗? - 瑞典早期产后抑郁症状的妇女的识别,干预和缓解:一个嵌套队列研究
Karin Gidén1, Lisa Vinnerljung2, Stavros I Iliadis1
1Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
概括
许多患有产后抑郁症症状的母亲没有被识别和治疗. 儿童健康服务的早期识别显著改善了症状的减少,突出了当前医疗保健过程中的差距.
科学领域:
- 产科和妇科 产科和妇科
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 产后抑郁症影响12%的母亲,影响家庭福祉.
- 许多患有抑郁症症状的女性仍未得到诊断和治疗.
- 本研究涉及医疗保健系统中产后抑郁症的识别和治疗.
研究的目的:
- 评估分娩后6周发现患有抑郁症状的女性的程度.
- 检查这些妇女接受的干预措施.
- 为了确定6个月的产后缓解率.
主要方法:
- 从BASIC队列研究中确定了产后妇女 (n=593) 的EPDS得分为12-30在6周.
- 从BASIC数据集中收集了6个月的缓解数据.
- 审查医疗记录以确定医疗保健干预措施.
主要成果:
- 58.7%的患有抑郁症症状的女性没有被医疗保健系统发现.
- 89%的未确定的妇女没有接受任何记录的干预措施,69%的妇女在6个月后得到缓解.
- 鉴定的女性的干预率更高 (90%),但缓解率更低 (50%).
- 儿童健康服务 (CHS) 的识别与最大的症状减轻相关.
结论:
- 尽管有查指南,但在识别和干预产后抑郁症方面存在重大差距.
- 很大一部分女性甚至在干预措施下也没有实现缓解.
- 通过CHS识别与更好的症状改善有关,这表明它在解决周周抑郁症方面的重要性.
相关概念视频
Depressive Disorders: MDD and Dysthymia
136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Community Based Intervention
43
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
43
Depressive Disorders: Etiology
102
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
102
Depression: Overview
247
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
247
Interpersonal Psychotherapy
27
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
27
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237


